Next Financial Group’s Travere Therapeutics TVTX Stock Holding History

Next Financial Group’s Portfolio TVTX Stock Details TVTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-11	Closed	–	–	2716
2021 Q1	$0	Buy	+11	New	+$304	﹤0.01%	2645
2015 Q4	–	Sell	-80	Closed	-$1K	–	1945
2015 Q3	$1K	Hold	80	–	–	﹤0.01%	1759
2015 Q2	$2K	Buy	+80	New	+$2.19K	﹤0.01%	1698

Other funds holding TVTX

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Next Financial Group's TVTX Position: Q2 2021 in Review

Next Financial Group sold out of Travere Therapeutics (TVTX) in Q2 2021, closing a stake of 11 shares.

Next Financial Group first reported a position in TVTX in Q2 2015 and held it in 3 quarters. The position peaked at $2K in Q2 2015. 136 funds tracked by Wall St. Rank hold TVTX as of Q2 2021.

Next Financial Group reported no remaining Travere Therapeutics position as of Q2 2021 after selling out during the quarter.
Next Financial Group sold 11 Travere Therapeutics shares in Q2 2021.
Next Financial Group first reported a position in Travere Therapeutics in Q2 2015 and held it in 3 quarters.
Next Financial Group's Travere Therapeutics position peaked at $2K in Q2 2015.
136 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2021.

Based on Next Financial Group's 13F filing for Q2 2021, filed 13 Jul 2021.